Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Rapid Micro Biosystems, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −11 vs. Q1 2026
- Shares held
- 17.5M
- +1.68M (+10.6%) vs. Q1 2026
- Total value
- $30.3M
- −$5.68M (−15.8%) vs. Q1 2026
- New holders
- 5
- 9 more added
- Sold out
- 16
- 13 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 15 | $26 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 35 | $61 | 0.00% | +35 | New |
| JPMorgan Chase & Co | 109 | $189 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 337 | $583 | 0.00% | −21,258−98.4% | Reduced |
| Tower Research Capital LLC (TRC) | 1,900 | $3.29K | 0.00% | +1,900 | New |
| UBS Group AG | 6,607 | $11.4K | 0.00% | −4,645−41.3% | Reduced |
| Larson Financial Group LLC | 8,395 | $14.5K | 0.00% | +2,904+52.9% | Added |
| Vanguard Global Advisers, LLC | 11,630 | $20.1K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 11,638 | $20.1K | 0.00% | −5,284−31.2% | Reduced |
| Nano Cap New Millennium Growth Fund L P | 12,500 | $21.6K | 0.02% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 14,300 | $24.7K | 0.00% | +300+2.1% | Added |
| Citadel Advisors LLC | 16,142 | $27.9K | 0.00% | +16,142 | New |
| HRT Financial LP | 23,093 | $39.0K | 0.00% | +23,093 | New |
| Jane Street Group, LLC | 25,931 | $44.9K | 0.00% | −106,994−80.5% | Reduced |
| Morgan Stanley | 27,587 | $47.7K | 0.00% | −1,620−5.5% | Reduced |
| Algert Global LLC | 38,307 | $66.3K | 0.00% | +15,126+65.3% | Added |
| Northern Trust Corp | 42,106 | $72.8K | 0.00% | −6,173−12.8% | Reduced |
| SEI Investments Co | 66,869 | $115.7K | 0.00% | −217,947−76.5% | Reduced |
| XTX Topco Ltd | 79,727 | $137.9K | 0.00% | +18,657+30.6% | Added |
| State Street Corp | 93,874 | $162.4K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 104,192 | $180.3K | 0.00% | +16,603+19.0% | Added |
| Vanguard Fiduciary Trust Co | 110,484 | $191.1K | 0.00% | +772+0.7% | Added |
| Legato Capital Management LLC | 119,534 | $206.8K | 0.02% | −155,390−56.5% | Reduced |
| BlackRock, Inc. | 189,832 | $328.4K | 0.00% | +32,600+20.7% | Added |
| Renaissance Technologies LLC | 212,101 | $366.9K | 0.00% | +85,484+67.5% | Added |
| Geode Capital Management, LLC | 228,041 | $394.7K | 0.00% | −19,136−7.7% | Reduced |
| Millennium Management LLC | 236,599 | $409.3K | 0.00% | −46,681−16.5% | Reduced |
| Essex Investment Management Co LLC | 362,696 | $627.5K | 0.08% | −521,235−59.0% | Reduced |
| Advent International Corp | 379,794 | $657.0K | 0.00% | −172,583−31.2% | Reduced |
| Evernest Financial Advisors, LLC | 506,000 | $875.4K | 0.18% | +73,490+17.0% | Added |
| Vanguard Capital Management LLC | 982,034 | $1.70M | 0.00% | −4600.0% | Reduced |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,848,296 | $3.20M | 37.39% | 00.0% | Unchanged |
| Armistice Capital, LLC | 3,328,000 | $5.76M | 0.16% | +3,328,000 | New |
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $14.6M | 0.87% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −212,114−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −120,773−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −71,912−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −71,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −31,014−100.0% | Sold out |
| Temasek Holdings (Private) Ltd | 0 | $0 | 0.00% | −21,818−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −21,200−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −15,900−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,410−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −15,224−100.0% | Sold out |
| Banco Bilbao Vizcaya Argentaria, S.A. | 0 | $0 | 0.00% | −12,691−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −12,524−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −9,327−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −719−100.0% | Sold out |
| Resources Management Corp | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |